Neuberger Berman Group’s Agios Pharmaceuticals AGIO Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q1 | – | Sell |
-9,670
| Closed | -$317K | – | 1899 |
|
2021
Q4 | $317K | Sell |
9,670
-18,637
| -66% | -$611K | ﹤0.01% | 1699 |
|
2021
Q3 | $1.3M | Sell |
28,307
-4,665
| -14% | -$215K | ﹤0.01% | 1251 |
|
2021
Q2 | $1.81M | Sell |
32,972
-5,360
| -14% | -$295K | ﹤0.01% | 1199 |
|
2021
Q1 | $1.98M | Sell |
38,332
-1,201
| -3% | -$61.9K | ﹤0.01% | 1156 |
|
2020
Q4 | $1.71M | Sell |
39,533
-1,048
| -3% | -$45.4K | ﹤0.01% | 1138 |
|
2020
Q3 | $1.42M | Sell |
40,581
-8,810
| -18% | -$308K | ﹤0.01% | 1126 |
|
2020
Q2 | $2.64M | Sell |
49,391
-1,401
| -3% | -$74.9K | ﹤0.01% | 954 |
|
2020
Q1 | $1.8M | Sell |
50,792
-26,806
| -35% | -$951K | ﹤0.01% | 968 |
|
2019
Q4 | $3.71M | Buy |
77,598
+10,899
| +16% | +$520K | ﹤0.01% | 904 |
|
2019
Q3 | $2.16M | Sell |
66,699
-24,440
| -27% | -$792K | ﹤0.01% | 994 |
|
2019
Q2 | $4.55M | Sell |
91,139
-4,624
| -5% | -$231K | 0.01% | 872 |
|
2019
Q1 | $6.46M | Sell |
95,763
-167,853
| -64% | -$11.3M | 0.01% | 808 |
|
2018
Q4 | $12.2M | Sell |
263,616
-79,775
| -23% | -$3.68M | 0.02% | 700 |
|
2018
Q3 | $26.5M | Buy |
343,391
+5,036
| +1% | +$388K | 0.03% | 563 |
|
2018
Q2 | $28.5M | Buy |
338,355
+103,415
| +44% | +$8.71M | 0.03% | 549 |
|
2018
Q1 | $19.2M | Buy |
234,940
+218,730
| +1,349% | +$17.9M | 0.02% | 642 |
|
2017
Q4 | $927K | Buy |
+16,210
| New | +$927K | ﹤0.01% | 1232 |
|
2015
Q2 | – | Sell |
-7,865
| Closed | -$742K | – | 1557 |
|
2015
Q1 | $742K | Buy |
7,865
+5,549
| +240% | +$524K | ﹤0.01% | 1264 |
|
2014
Q4 | $259K | Buy |
+2,316
| New | +$259K | ﹤0.01% | 1485 |
|